Back to Home

🔍 Search RISP Database

Search across 69,000+ products, devices, trials, documents, and organizations

117
Total Results
21
Countries
5
Module Types
195ms
Response Time

📍 Results by Country

Unknown (37) BOTSWANA (36) UGANDA (13) Tunisia (5) Uganda (5) Madagascar (3) Somalia (2) Ivory Coast (2) Guinea (2) Nigeria (1)
117 results found for "trial" (195ms)
Show Paginated Clear Results
Type Title & Description Details Country Status
Trial
Trial of a Novel Nutritional Supplement for Pregnant Women to Prevent Low Birth Weight
Biologics - European Union Humanitarian Aid - Action Contre la Faim Madagascar
Mfr: European Union Humanitarian Aid
Applicant: Action Contre la Faim Madagascar
Sponsor: European Union Humanitarian Aid
Cat: Biologics
Type: Biologics
📅 Sep 18, 2024
● Madagascar
Recruiting
Document
AfCFTA AIDA_Industrialization Progress Assessment_Sectors_vPlatform _694248fb1da6e.xlsx
1
Cat: Document
📅 Oct 25, 2026
— Active
Trial
A multi-country, multi-centre, two arm, parallel, double blind, placebo controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low resource countries to improve newborn out
Biologics - World Health Organization - Dr Idowu Ayede
Mfr: World Health Organization
Applicant: Dr Idowu Ayede
Sponsor: World Health Organization
Cat: Biologics
Type: Biologics
— Approved
Trial
A multi-country, multi-centre, two arm, parallel, double blind, placebo- controlled, randomized trial of antenatal corticosteriods for women at risk of imminent birth in the late preterm period in hospitals in low resource countries to improve newborn out
Drug - Department of Reproductive Health & Research, World Health Organisation - Dr Adejumoke Idowu Ayede
Mfr: Department of Reproductive Health & Research, World Health Organisation
Applicant: Dr Adejumoke Idowu Ayede
Sponsor: Department of Reproductive Health & Research, World Health Organisation
Cat: Drug
Type: Drug
— Approved
Trial
A multi-country, multi-centre, two-arm, parallel, double blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low resource countries to improve newborn out
Drug - World Health Organization - Prof Oluwafemi Kuti
Mfr: World Health Organization
Applicant: Prof Oluwafemi Kuti
Sponsor: World Health Organization
Cat: Drug
Type: Drug
— Approved
Trial
A multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteriods for women at risk of imminent birth in the late preterm period in hospitals in low-resource countries to improve newborn outc
Drug - World Health Organization - Prof Olufemi Kuti
Mfr: World Health Organization
Applicant: Prof Olufemi Kuti
Sponsor: World Health Organization
Cat: Drug
Type: Drug
— Approved
Trial
A Multicentre, Double blind, Randomized, parallel group, clinical trial to compare the sexual pleasure, performance, acceptability and safety of Graphene incorporated natural rubber latex condoms and natural rubber latex compounds in healthy humans.
Vaccine - The George Institute for Global Health, - Xcene Research Ltd
Mfr: The George Institute for Global Health,
Applicant: Xcene Research Ltd
Sponsor: The George Institute for Global Health,
Cat: Vaccine
Type: Vaccine
— Approved
Trial
A Phase 2/3 Trial of a New Oral Cholera Vaccine in High-Risk Populations
Vaccine - Gavi, the Vaccine Alliance, International Vaccine Institute - African Medical Research Foundation (AMREF) Somalia
Mfr: Gavi, the Vaccine Alliance, International Vaccine Institute
Applicant: African Medical Research Foundation (AMREF) Somalia
Sponsor: Gavi, the Vaccine Alliance, International Vaccine Institute
Cat: Vaccine
Type: Vaccine
📅 Aug 30, 2024
● Somalia
Active
Trial
A phase III, randomised, double-blind, active, controlled, multinational, multicentre, non-inferiority trial using Carbetocin room temperature stable (RTS) for the prevention of postpartum haemorrhage during the third stage of labour in women delivering v
Drug - Department of Reproductive Health & Research, World Health Organization - Dr Bukola Fawole
Mfr: Department of Reproductive Health & Research, World Health Organization
Applicant: Dr Bukola Fawole
Sponsor: Department of Reproductive Health & Research, World Health Organization
Cat: Drug
Type: Drug
— Approved
Trial
A phase III, randomized, double blind, active, controlled, multi national, multicentre, non-inferiority trial using Carbetocin room temperature stable (RTS) for the prevention of post partum haemorrhage during the third stage of labour in women delivering
Drug - Department of Reproductive Heath & Research, World Health Organization - Dr Bukola Fawole
Mfr: Department of Reproductive Heath & Research, World Health Organization
Applicant: Dr Bukola Fawole
Sponsor: Department of Reproductive Heath & Research, World Health Organization
Cat: Drug
Type: Drug
— Approved
Trial
A Phase IIIB/IV Randomized Open-label Trial Comparing Dolutegravir with Predetermined Nucleosides Versus Recommended Standard of Care ART R regimens in Patients with HIV-1 Infection Failing First Line Therapy
Drug - University of New South Wales - The Institute of Human Virology-IHVN
Mfr: University of New South Wales
Applicant: The Institute of Human Virology-IHVN
Sponsor: University of New South Wales
Cat: Drug
Type: Drug
— Approved
Trial
A randomized Controlled Trial of Influenza Vaccine to Prevent Adverse Vascular Events
Vaccine - McMaster University - Prof Kamilu M. Karaye
Mfr: McMaster University
Applicant: Prof Kamilu M. Karaye
Sponsor: McMaster University
Cat: Vaccine
Type: Vaccine
— Approved
Trial
An investigator initiated and conducted, multicentre, international, double-blinded, placebo-controlled, parallel group, randomized controlled trial to determine the effect of more intensive blood pressure control provided by a fixed low-dose combination
Drug - The George Institute for Global Health - Xcene Research Ltd
Mfr: The George Institute for Global Health
Applicant: Xcene Research Ltd
Sponsor: The George Institute for Global Health
Cat: Drug
Type: Drug
— Approved
Trial
ClustEr randomised Trial of sterile glove and instrument change at the time of wound closure to reduce surgical site infection in low and middle income counties (LMICs)
Procedure - University of Birmingham - NIHR GSU Lagos Hub, College of Medicine, University of lagos
Mfr: University of Birmingham
Applicant: NIHR GSU Lagos Hub, College of Medicine, University of lagos
Sponsor: University of Birmingham
Cat: Procedure
Type: Procedure
— Approved
Trial
Implementation Trial of a New Maternity Care Bundle to Reduce Postpartum Hemorrhage
Procedure - UNFPA, University of Montreal - UNFPA Burundi
Mfr: UNFPA, University of Montreal
Applicant: UNFPA Burundi
Sponsor: UNFPA, University of Montreal
Cat: Procedure
Type: Procedure
📅 Feb 06, 2026
— Active
Trial
Investigation of Rheumatic AF Treatment Using Vitamin K antagonists, Rivaroxaban or Aspirin Studies (INVICTUS Trials)
Drug - Hamilton Health Science, Hamilton, Ontario, Canada - Dr. Okechwukwu S. Ogah
Mfr: Hamilton Health Science, Hamilton, Ontario, Canada
Applicant: Dr. Okechwukwu S. Ogah
Sponsor: Hamilton Health Science, Hamilton, Ontario, Canada
Cat: Drug
Type: Drug
— Approved
Trial
Pragmatic multicentre Factorial randomized controlled trial testing measures of reducing surgical site infection in low and middle income countries
Procedure - University of Birmingham - NIHR GSU Lagos Hub, College of Medicine, University of Lagos
Mfr: University of Birmingham
Applicant: NIHR GSU Lagos Hub, College of Medicine, University of Lagos
Sponsor: University of Birmingham
Cat: Procedure
Type: Procedure
— Approved
Trial
Primary Prevention of Stroke in Nigerian Children with Sickle Cell Disease in Sub Saharan Africa II: a partial double blind randomized Phase III clinical trial
Drug - Vanderbilt University School of Medicine - Aminu Kano Teaching Hospital
Mfr: Vanderbilt University School of Medicine
Applicant: Aminu Kano Teaching Hospital
Sponsor: Vanderbilt University School of Medicine
Cat: Drug
Type: Drug
— Approved
Trial
Tranexamic acid for the treatment of gastrointestinal bleeding: an international randomised, double blind placebo control trial
Drug - London School of Hygiene & Tropical Medicine - Prof. Bukonla Fawole
Mfr: London School of Hygiene & Tropical Medicine
Applicant: Prof. Bukonla Fawole
Sponsor: London School of Hygiene & Tropical Medicine
Cat: Drug
Type: Drug
— Approved
Trial
Traxenamic acid for reducing postpartum bleeding in women with anaemia: an international, randomized, double blind, placebo controlled trial.b
Drug - London School of Hygiene and Tropical Medicine - Prof Oladapo Olayemi
Mfr: London School of Hygiene and Tropical Medicine
Applicant: Prof Oladapo Olayemi
Sponsor: London School of Hygiene and Tropical Medicine
Cat: Drug
Type: Drug
— Approved
Trial
Traxenamic acid for the treatment of postpartum haemorrhage: An international, randomised, double blind placebo controlled trial
Drug - London School of Hygiene & Tropical Medicine - Prof Bukola Fawole
Mfr: London School of Hygiene & Tropical Medicine
Applicant: Prof Bukola Fawole
Sponsor: London School of Hygiene & Tropical Medicine
Cat: Drug
Type: Drug
— Approved
Trial
Traxenamic acid for the treatment of significant traumatic brain injury: an international randomised, double blind placembo controlled trial
Drug - London School of Hygiene & Tropical Medicine - Prof. Bukola Fawole
Mfr: London School of Hygiene & Tropical Medicine
Applicant: Prof. Bukola Fawole
Sponsor: London School of Hygiene & Tropical Medicine
Cat: Drug
Type: Drug
— Approved
Trial
A Phase 2b Trial of a Therapeutic HIV Vaccine in Adults Initiating Antiretroviral Therapy in Malawi
Vaccine - International AIDS Vaccine Initiative (IAVI) - Kamuzu University of Health Sciences
Mfr: International AIDS Vaccine Initiative (IAVI)
Applicant: Kamuzu University of Health Sciences
Sponsor: International AIDS Vaccine Initiative (IAVI)
Cat: Vaccine
Type: Vaccine
📅 Feb 06, 2026
— Not yet recruiting
Trial
A Phase III Randomized Trial of Artemisinin-based Combination Therapy for Uncomplicated Malaria in Sub-Saharan Africa
Drug - World Health Organization - University of Lagos Teaching Hospital
Mfr: World Health Organization
Applicant: University of Lagos Teaching Hospital
Sponsor: World Health Organization
Cat: Drug
Type: Drug
📅 Feb 06, 2026
● Nigeria
Recruiting
Trial
A Phase III Trial of a New Antimalarial Drug in Burundi
Drug - Burundi Ministry of Health, WHO - Burundi Ministry of Health
Mfr: Burundi Ministry of Health, WHO
Applicant: Burundi Ministry of Health
Sponsor: Burundi Ministry of Health, WHO
Cat: Drug
Type: Drug
📅 Feb 06, 2026
— Recruiting
Trial
A Randomized Controlled Trial of a New Anthelmintic Drug for Soil-Transmitted Helminthiasis
Drug - Swiss Tropical and Public Health Institute - Madagascar Institute of Public Health
Mfr: Swiss Tropical and Public Health Institute
Applicant: Madagascar Institute of Public Health
Sponsor: Swiss Tropical and Public Health Institute
Cat: Drug
Type: Drug
📅 Nov 14, 2024
● Madagascar
Recruiting
Trial
A Randomized Controlled Trial of a New Hemostatic Dressing for Trauma Wounds in Conflict-Affected Settings in South Sudan
Device - U.S. Army Medical Research and Development Command - Médecins Sans Frontières (MSF)
Mfr: U.S. Army Medical Research and Development Command
Applicant: Médecins Sans Frontières (MSF)
Sponsor: U.S. Army Medical Research and Development Command
Cat: Device
Type: Device
📅 Feb 06, 2026
— Not yet recruiting
Trial
A Randomized Controlled Trial of a New Wound Dressing for Conflict-Related Injuries
Device - Médecins Sans Frontières Operational Center Brussels - Médecins Sans Frontières (MSF) Somalia
Mfr: Médecins Sans Frontières Operational Center Brussels
Applicant: Médecins Sans Frontières (MSF) Somalia
Sponsor: Médecins Sans Frontières Operational Center Brussels
Cat: Device
Type: Device
📅 Jan 12, 2025
● Somalia
Recruiting
Trial
A Randomized Trial of Two Antiretroviral Therapy Regimens in Burundi
Drug - National AIDS Control Program Burundi, PEPFAR - National AIDS Control Program Burundi
Mfr: National AIDS Control Program Burundi, PEPFAR
Applicant: National AIDS Control Program Burundi
Sponsor: National AIDS Control Program Burundi, PEPFAR
Cat: Drug
Type: Drug
📅 Feb 06, 2026
— Recruiting
Trial
A Trial of a Novel Nutritional Supplement for Moderate Acute Malnutrition (MAM) in Children Under Five in South Sudan
Biologics - Washington University in St. Louis - World Food Programme (WFP)
Mfr: Washington University in St. Louis
Applicant: World Food Programme (WFP)
Sponsor: Washington University in St. Louis
Cat: Biologics
Type: Biologics
📅 Feb 06, 2026
— Active, not recruiting
Trial
A Trial of Ivermectin Mass Drug Administration for Malaria Control in Southern Malawi (IMDA-MW)
Drug - National Institutes of Health (NIH) - Michigan State University - Malawi Program
Mfr: National Institutes of Health (NIH)
Applicant: Michigan State University - Malawi Program
Sponsor: National Institutes of Health (NIH)
Cat: Drug
Type: Drug
📅 Feb 06, 2026
— Enrolling by invitation
Trial
A Trial of New First-line Antiretroviral Therapy Regimens in Malawi (NEWFIRST)
Drug - Ministry of Health, Malawi - Lighthouse Trust
Mfr: Ministry of Health, Malawi
Applicant: Lighthouse Trust
Sponsor: Ministry of Health, Malawi
Cat: Drug
Type: Drug
📅 Feb 06, 2026
— Recruiting
Trial
Community-Based Randomized Trial of a New Water Purification Solution for the Prevention of Diarrheal Diseases
Device - Centers for Disease Control and Prevention (CDC) - Oxfam
Mfr: Centers for Disease Control and Prevention (CDC)
Applicant: Oxfam
Sponsor: Centers for Disease Control and Prevention (CDC)
Cat: Device
Type: Device
📅 Feb 06, 2026
— Recruiting
Trial
Investigation of the Potential Beneficial Effects of Cannabidiol in the management of Tardive Dyskinesia using Animal Studies and a clinical trial
Drug - South Africa Research Chair in PTSD, Department of Psychiatry, Stellenbosch University - Dr Jaiyeola Abiola Kajero
Mfr: South Africa Research Chair in PTSD, Department of Psychiatry, Stellenbosch University
Applicant: Dr Jaiyeola Abiola Kajero
Sponsor: South Africa Research Chair in PTSD, Department of Psychiatry, Stellenbosch University
Cat: Drug
Type: Drug
— Rejected
Trial
malai Clinical Trial - Phase III
vacine - Global Health Foundation - Test Pharmaceuticals Ltd
Mfr: Global Health Foundation
Applicant: Test Pharmaceuticals Ltd
Sponsor: Global Health Foundation
Cat: vacine
Type: vacine
📅 Dec 15, 2025
—
Trial
Phase 2b Trial of a Bivalent HPV Vaccine in Adolescent Girls
Vaccine - Gavi, the Vaccine Alliance - Ministry of Public Health of Madagascar
Mfr: Gavi, the Vaccine Alliance
Applicant: Ministry of Public Health of Madagascar
Sponsor: Gavi, the Vaccine Alliance
Cat: Vaccine
Type: Vaccine
📅 May 15, 2024
● Madagascar
Recruiting
Trial
Phase II Trial of a Repurposed Drug for Multidrug-Resistant Tuberculosis
Drug - Médecins Sans Frontières - Médecins Sans Frontières
Mfr: Médecins Sans Frontières
Applicant: Médecins Sans Frontières
Sponsor: Médecins Sans Frontières
Cat: Drug
Type: Drug
📅 Feb 06, 2026
— Recruiting
Trial
Test Clinical Trial - Phase III
Drug - Global Health Foundation - Test Pharmaceuticals Ltd
Mfr: Global Health Foundation
Applicant: Test Pharmaceuticals Ltd
Sponsor: Global Health Foundation
Cat: Drug
Type: Drug
📅 Dec 15, 2025
—
Training
Experts in charge of clinical trials and approval (Online)
NRA
● Ivory Coast
Identified
Training
Pharmacists in charge of clinical trials and pharmacovigilance and inspections (In-person)
NRA
● Ivory Coast
Identified
Training
Experts in charge of clinical trials and approval (In-person)
NRA
● Guinea
Identified
Training
Pharmacists in charge of clinical trials and pharmacovigilance and inspections (In-person)
NRA
● Guinea
Identified
Training
Clinical Trial Unit Staff (In-person)
NRA
● Liberia
Identified
Training
Clinical trial staff (Hybrid)
NRA
● Burkina Faso
Identified
Training
Clinical Trial Officers (In-person)
NRA
● Tanzania
Identified
Training
Member of the Technical Committee for the Evaluation of Clinical Trials (In-person)
NRA
● Niger
Identified
Training
Staff Involved in Cell Culture Trials (In-person)
NRA
● Algeria
Identified
Training
ANMPS clinical trial evaluator (In-person)
NRA
● Tunisia
Identified
Training
ANMPS clinical trial evaluator (In-person)
NRA
● Tunisia
Identified
Training
ANMPS clinical trial evaluator + Inspectors (In-person)
NRA
● Tunisia
Identified
Training
Phase III Trials (Hybrid)
NRA
● Kenya
Identified
Training
Regulatory oversight for Decentralized Clinical Trials and digital health technologies (Hybrid)
NRA
● Ethiopia
Planning
Training
Clinical trial applications for medical devices (In-person)
NRA
● Eswatini
Planning
Training
Digital Health and AI in Clinical Trials (Online)
NRA
● Uganda
Planning
Training
Complex clinicial trial designs and IMPs (Online)
NRA
● Uganda
Planning
Training
Haemovigilance in clinical trials and other post authorised drug products (In-person)
NRA
● Uganda
Planning
Training
Clinical trials assesment involving vaccines and other biological products (In-person)
NRA
● Uganda
Planning
Training
Statistical assessment of clincial trials (Online)
NRA
● Uganda
Planning
Training
USE Industrial Radiography Licensing and Authorization (Hybrid)
NRA
● South Africa
Planning
Resource
Clinical Trials Guidelines in Kenya (PDF)
National regulatory authority guidance, laws, procedures, portals and publications (multi-language where available).
Cat: National Regulatory Authorities (NRAs) – Country Guidance & Publications
— —
Trial
Evaluation of a Rapid Diagnostic Algorithm for Surgical Site Infections
Procedure - European and Developing Countries Clinical Trials Partnership - Hospital Sanatório de Luanda
Mfr: European and Developing Countries Clinical Trials Partnership
Applicant: Hospital Sanatório de Luanda
Sponsor: European and Developing Countries Clinical Trials Partnership
Cat: Procedure
Type: Procedure
📅 Feb 06, 2026
● Angola
Recruiting
Resource
AVAREF Overview (WHO AFRO)
Resources supporting harmonised oversight of vaccines, clinical trials, emergency preparedness and joint regulatory reviews, including AVAREF guidance...
Cat: Vaccines, Clinical Trials & Regulatory Preparedness (AVAREF and related)
— —
Resource
AVAREF Guidelines
Resources supporting harmonised oversight of vaccines, clinical trials, emergency preparedness and joint regulatory reviews, including AVAREF guidance...
Cat: Vaccines, Clinical Trials & Regulatory Preparedness (AVAREF and related)
— —
Resource
AVAREF Technical Committee (AMRH)
Resources supporting harmonised oversight of vaccines, clinical trials, emergency preparedness and joint regulatory reviews, including AVAREF guidance...
Cat: Vaccines, Clinical Trials & Regulatory Preparedness (AVAREF and related)
— —
Resource
AVAREF Strategy & Emergency Preparedness
Resources supporting harmonised oversight of vaccines, clinical trials, emergency preparedness and joint regulatory reviews, including AVAREF guidance...
Cat: Vaccines, Clinical Trials & Regulatory Preparedness (AVAREF and related)
— —
Product
ABACAVIR (AS SULFATE) / LAMIVUDINE DISPERSIBLE TABLETS
Reg: NDA/MAL/HDP/9266
Mfr: MYLAN LABORATORIES LIMITED
📅 Sep 08, 2020
● UGANDA
APPROVED
Product
ABACAVIR SULFATE & LAMIVUDINE 600MG/300MG FILM COATED TABLETS
Reg: BOT1502775
Mfr: HETERO LABS LTD (UNIT-V),SY. NO: 439, 440, 441 & 458,APIIC FORMULATION SEZ, POLEPALLY (V),JADCHERLA (M), MAHABOOBNAGAR DIST ANDHRA PRADESH. INDIA,
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ABACAVIR SULFATE 300 MG FILM COATED TABLETS
Reg: BOT1703069
Mfr: 1.HETERO LABS LIMITED, UNIT III, 22-110, IDA, JEEDIMETLA, HYDERABAD, 500055, TELANGANA, INDIA 2.PYRAMID PHARMA, PLOT 28911, UNIT 2-F-1 GABORONE WEST INDUSTRIAL, BOTSWANA (ADDITIONAL PACKER) 3.MDB PHARMA (PTY) LTD, PLOT 1104, SEKOLWANA INDUSTRIAL, TLOKW
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ABACAVIR SULPHATE ORAL SOLUTION
Reg: NDA/MAL/HDP/0209
Mfr: HETERO LABS LTD
📅 Jul 01, 2013
● UGANDA
APPROVED
Product
ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE 600MG/50MG/300MG FILM-COATEDTABLETS
Reg: BOT2404169
Mfr: HETERO LABS LIMITED (UNIT -V), SURVEY NO. 439, 440, 441 & 458, TSIIC-FORMULATION SEZ, POLEPALLY (VILLAGE), JADCHERLA (MANDAL), MAHABOOB NAGAR (DIST) TELANGANA STATE, INDIA – 509301
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE 600MG/50MG/300MG FILM-COATEDTABLETS
Reg: BOT2404169A
Mfr: HETERO LABS LIMITED (UNIT -V), SURVEY NO. 439, 440, 441 & 458, TSIIC-FORMULATION SEZ, POLEPALLY (VILLAGE), JADCHERLA (MANDAL), MAHABOOB NAGAR (DIST) TELANGANA STATE, INDIA – 509301
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ABACAVIR, DOLUTEGRAVIR AND LAMIVUDINE 600MG/50MG/300MG FILM-COATEDTABLETS
Reg: BOT2404169B
Mfr: HETERO LABS LIMITED (UNIT -V), SURVEY NO. 439, 440, 441 & 458, TSIIC-FORMULATION SEZ, POLEPALLY (VILLAGE), JADCHERLA (MANDAL), MAHABOOB NAGAR (DIST) TELANGANA STATE, INDIA – 509301
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ABAGANIL 150 MG TABLETS
Reg: BOT1903571
Mfr: MYLAN LABORATORIES LTD, PLOT NO. H-12 & H-13 MIDC, WALUJ INDUSTRIAL ESTATE, AURANGABAD - 431136, MAHARASHTRA, INDIA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ABAGANIL 75 MG TABLET
Reg: BOT1903570
Mfr: MYLAN LABORATORIES LTD, PLOT NO. H-12 & H-13 MIDC, WALUJ INDUSTRIAL ESTATE, AURANGABAD - 431136, MAHARASHTRA, INDIA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ABLEPT_300 300MG CAPSULE
Reg: PMPB/PL106/88
Mfr: MICRO LABS LIMITED, 92, SIPCOT INDUSTRIAL COMPLEX
📅 Jan 02, 1965
● MALAWI
APPROVED
Product
ACCOFIL 30MCG/0.5ML SOLUTION FOR INJECTION
Reg: BOT2103703
Mfr: INTAS PHARMACEUTICALS LTD, PLOT NO. 423 / P / A, SARKHEJ – BAVLA HIGHWAY VILLAGE MORAIYA, TALUKA SANAND AHMEDABAD – 382213 GUJARAT, INDIA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACEM-500
Reg: NDA/MAL/HDP/2160
Mfr: EMCURE PHARMACEUTICALS LTD
📅 Jul 01, 2005
● UGANDA
APPROVED
Product
ACETAZOLAMIDE
Reg: NDA/MAL/HDP/8699
Mfr: REMEDICA LTD
📅 May 30, 2018
● UGANDA
APPROVED
Product
ACETAZOLAMIDE 250MG TABLETS
Reg: BOT9800134A
Mfr: REMEDICA LTD AHARNON STREET, LIMASSOL INDUSTRIAL ESTATE,3056 LIMASSOL, CYPRUS.
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACETAZOLAMIDE 250MG TABLETS
Reg: BOT9800134
Mfr: REMEDICA LTD AHARNON STREET, LIMASSOL INDUSTRIAL ESTATE,3056 LIMASSOL, CYPRUS.
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACETEN 12.5MG TABLETS
Reg: BOT0600857
Mfr: WOCKHARDT LIMITED , L-1 MIDC INDUSTRIAL AREA,JALGAON ROAD CHIKALTHANA, AURANGABAD 431210 INDIA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACETEN 25MGTABLETS
Reg: BOT0600858
Mfr: WOCKHARDT LIMITED , L-1 MIDC INDUSTRIAL AREA,JALGAON ROAD CHIKALTHANA, AURANGABAD 431210 INDIA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACETEN 50MG TABLETS
Reg: BOT0600859
Mfr: WOCKHARDT LIMITED , L-1 MIDC INDUSTRIAL AREA,JALGAON ROAD CHIKALTHANA, AURANGABAD 431210 INDIA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACITAB 200 DT TABLETS
Reg: BOT1101945
Mfr: CIPLA LTD., UNIT I - PLOT NO A-33/1/2, A-2& A-37/2/2, MIDC, PATALGANGA INDUSTRIAL AREAD, DISTRICT RAIGAD, MAHARASHTRA INDIA MEDITAB SPECIALITIES PVT. LTD, ESTATE, KUNDAIM, GOA - 403115, INDIA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACITAB 400 DT
Reg: BOT1101946C
Mfr: CIPLA LTD., UNIT I - PLOT NO A-33/1/2, A-2& A-37/2/2, MIDC, PATALGANGA INDUSTRIAL AREAD, DISTRICT RAIGAD, MAHARASHTRA INDIA MEDITAB SPECIALITIES PVT. LTD, ESTATE, KUNDAIM, GOA - 403115, INDIA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACITAB 400 DT TABLETS
Reg: BOT1101946B
Mfr: CIPLA LTD., UNIT I - PLOT NO A-33/1/2, A-2& A-37/2/2, MIDC, PATALGANGA INDUSTRIAL AREAD, DISTRICT RAIGAD, MAHARASHTRA INDIA MEDITAB SPECIALITIES PVT. LTD, ESTATE, KUNDAIM, GOA - 403115, INDIA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACITAB 400 DT TABLETS
Reg: BOT1101946A
Mfr: CIPLA LTD., UNIT I - PLOT NO A-33/1/2, A-2& A-37/2/2, MIDC, PATALGANGA INDUSTRIAL AREAD, DISTRICT RAIGAD, MAHARASHTRA INDIA MEDITAB SPECIALITIES PVT. LTD, ESTATE, KUNDAIM, GOA - 403115, INDIA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACME’S WATER FOR INJECTION
Reg: BOT1703026
Mfr: THE ACME LABORATORIES LTD, BFS, LIQUID & SEMI-SOLID UNIT, DHAMRAI, DHAKA, BANGLADESH
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACME’S WATER FOR INJECTION
Reg: BOT1703026A
Mfr: THE ACME LABORATORIES LTD, BFS, LIQUID & SEMI-SOLID UNIT, DHAMRAI, DHAKA, BANGLADESH
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACNOTIN 10
Reg: NDA/MAL/HDP/4719
Mfr: MEGA LIFESCIENCES (AUSTRALIA) PTY LTD
📅 Jul 01, 2011
● UGANDA
APPROVED
Product
ACNOTIN 20
Reg: NDA/MAL/HDP/4718
Mfr: MEGA LIFESCIENCES (AUSTRALIA) PTY LTD
📅 Jul 01, 2011
● UGANDA
APPROVED
Product
ACRIPTEGA 300/300/50 MG TABLET
Reg: BOT1703219B
Mfr: 1.MYLAN LABORATORIES LTD, PLOT NO.11, 12 & 13, INDORE SPECIAL ECONOMIC ZONE, PHARMA ZONE, PHASE-II, SECTOR-III, PITHAMPUR-454775, DIST. DHAR, MADHYA PRADESH, INDIA. 2. MYLAN LABORATORIES LIMITED. PLOT NO. H-12 AND H-13, MIDC, WALUJ INDUSTRIAL AREA, AURAN
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACRIPTEGA 300/300/50 MG TABLET
Reg: BOT1703219A
Mfr: 1.MYLAN LABORATORIES LTD, PLOT NO.11, 12 & 13, INDORE SPECIAL ECONOMIC ZONE, PHARMA ZONE, PHASE-II, SECTOR-III, PITHAMPUR-454775, DIST. DHAR, MADHYA PRADESH, INDIA. 2. MYLAN LABORATORIES LIMITED. PLOT NO. H-12 AND H-13, MIDC, WALUJ INDUSTRIAL AREA, AURAN
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACRIPTEGA 300/300/50 MG TABLET
Reg: BOT1703219
Mfr: 1.MYLAN LABORATORIES LTD, PLOT NO.11, 12 & 13, INDORE SPECIAL ECONOMIC ZONE, PHARMA ZONE, PHASE-II, SECTOR-III, PITHAMPUR-454775, DIST. DHAR, MADHYA PRADESH, INDIA. 2. MYLAN LABORATORIES LIMITED. PLOT NO. H-12 AND H-13, MIDC, WALUJ INDUSTRIAL AREA, AURAN
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACTION TABLETS
Reg: NDA/MAL/HDP/1785
Mfr: BETA HEALTHCARE UGANDA LIMITED
📅 Jul 01, 1997
● UGANDA
APPROVED
Product
ACTITOP
Reg: NDA/MAL/HDP/6506
Mfr: KHANDELWAL LABORATORIES PVT LIMITED
📅 May 29, 2019
● UGANDA
APPROVED
Product
ACTIVATED CHARCOAL TABLETS
Reg: NDA/MAL/HHP/10027
Mfr: BHARGAVA PHYTOLAB PVT. LTD
📅 Apr 21, 2022
● UGANDA
APPROVED
Product
ACTRAPID FLEXPEN 100 I.U/ML
Reg: NDA/MAL/HDP/2800
Mfr: NOVO NORDISK
📅 Jul 01, 1997
● UGANDA
APPROVED
Product
ACUCIP (CIPROFLOXACIN 0.2 % IV INFUSION)
Reg: BOT1302340
Mfr: ACULIFE HEALTHCARE PRIVATE LIMITED VILLAGE: SACHANA, TALUKA: VIRAMGAM, DISTRICT: AHMEDABAD – 382 150, GUJARAT, INDIANIRMA LTD (HEALTH CARE DIVISION SACHANA, VIRAMGAM, AHMEDABAD-382150, GUJARAT INDIA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ACURON
Reg: NDA/MAL/HDP/7463
Mfr: BROOKES PHARMA (PRIVATE) LIMITED
📅 Aug 27, 2019
● UGANDA
APPROVED
Product
ADCO CEFAZOLIN 1G POWDER FOR INJECTION
Reg: BOT1001745
Mfr: 1.BIOPHARMA S.R.L., ITALY. ARDEATINE KM., 21 ,500 VIA DELLE GERBERE 20/22, 00040 SANTA PALOMBA (ROMA), ITALY 2.ACS DOBFAR S.P.A. NUCLEO LNDUSTRIALE, S. ATTO, S. NICOLO A, TORDINO, 64100 TERAMO, ITALY 3.ADCOCK INGRAM CRITICAL CARE (PTY) LTD, SOUTH AFRICA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ADCO LOPERAMIDE 2 MG TABLETS
Reg: BOT1402531B
Mfr: ADCOCK INGRAM LTD. 49 (C & D), BOMMASANDRA INDUSTRIAL AREA, ANEKAL TALUK,BANGALORE – 560099 INDIA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ADCO LOPERAMIDE 2 MG TABLETS
Reg: BOT1402531A
Mfr: ADCOCK INGRAM LTD. 49 (C & D), BOMMASANDRA INDUSTRIAL AREA, ANEKAL TALUK,BANGALORE – 560099 INDIA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ADCO LOPERAMIDE 2 MG TABLETS
Reg: BOT1402531C
Mfr: ADCOCK INGRAM LTD. 49 (C & D), BOMMASANDRA INDUSTRIAL AREA, ANEKAL TALUK,BANGALORE – 560099 INDIA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ADCO-ATORVASTATIN 10MG TABLETS
Reg: BOT1402649
Mfr: 1)ACTAVIS HF REYKJAVIKURVEGUR 78, IS-220 HAFNARFJORDUR,ICELAND 2) ACTAVIS LTD BLB016 BLUEBEL INDUSTRIAL ESTATE ZEJTUN ZTN 3000 MALTA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ADCO-ATORVASTATIN 20MG TABLETS
Reg: BOT1402648
Mfr: 1)ACTAVIS HF REYKJAVIKURVEGUR 78, IS-220 HAFNARFJORDUR,ICELAND 2) ACTAVIS LTD BLB016 BLUEBEL INDUSTRIAL ESTATE ZEJTUN ZTN 3000 MALTA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ADCO-ATORVASTATIN 40MG TABLETS
Reg: BOT1402647
Mfr: 1)ACTAVIS HF REYKJAVIKURVEGUR 78, IS-220 HAFNARFJORDUR,ICELAND 2) ACTAVIS LTD BLB016 BLUEBEL INDUSTRIAL ESTATE ZEJTUN ZTN 3000 MALTA
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ADCO-DOL TABLET
Reg: BOT1803275B
Mfr: ADCOCK INGRAM LTD (INDIA),NO. 49 (C AND D), BOMMASANDRA INDUSTRIAL AREA,ANEKAL TALUK, BANGALORE, 560 099, INDIA.
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ADCO-DOL TABLET
Reg: BOT1803275A
Mfr: ADCOCK INGRAM LTD (INDIA),NO. 49 (C AND D), BOMMASANDRA INDUSTRIAL AREA,ANEKAL TALUK, BANGALORE, 560 099, INDIA.
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ADCO-DOL TABLET
Reg: BOT1803275
Mfr: ADCOCK INGRAM LTD (INDIA),NO. 49 (C AND D), BOMMASANDRA INDUSTRIAL AREA,ANEKAL TALUK, BANGALORE, 560 099, INDIA.
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ADCO-IBUPROFEN 400 MG
Reg: NDA/MAL/HDP/9624
Mfr: ADCOCK INGRAM LIMITED
📅 Jun 03, 2021
● UGANDA
APPROVED
Product
ADCO-NAPACOD TABLET
Reg: BOT1803274A
Mfr: ADCOCK INGRAM LTD (INDIA),NO. 49 (C AND D), BOMMASANDRA INDUSTRIAL AREA,ANEKAL TALUK, BANGALORE, 560 099, INDIA.
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ADCO-NAPACOD TABLET
Reg: BOT1803274
Mfr: ADCOCK INGRAM LTD (INDIA),NO. 49 (C AND D), BOMMASANDRA INDUSTRIAL AREA,ANEKAL TALUK, BANGALORE, 560 099, INDIA.
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Product
ADCO-NAPAMOL
Reg: NDA/MAL/HDP/6758
Mfr: ADCOCK INGRAM LIMITED
📅 Jul 01, 2016
● UGANDA
APPROVED
Product
ADCO-NAPAMOL 500 MG TABLETS
Reg: BOT1803272A
Mfr: ADCOCK INGRAM LTD (INDIA),NO. 49 (C AND D), BOMMASANDRA INDUSTRIAL AREA,ANEKAL TALUK, BANGALORE, 560 099, INDIA.
📅 Jan 02, 1965
● BOTSWANA
APPROVED
Training
Good clinical practices (Hybrid)
NRA
● Tunisia
Planning
Training
Good practices in animal testing (Hybrid)
NRA
● Tunisia
Planning